William Blair & Company’s Astrana Health ASTH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$832K Sell
23,394
-3,292
-12% -$130K ﹤0.01% 1021
2026
Q2
$1.24M Sell
26,686
-5,184
-16% -$187K ﹤0.01% 905
2026
Q1
$781K Sell
31,870
-11,031
-26% -$261K ﹤0.01% 1018
2025
Q4
$1.06M Buy
+42,901
New +$1.14M ﹤0.01% 922

Other funds holding ASTH

William Blair & Company's ASTH Position: Q3 2026 in Review

William Blair & Company reduced its Astrana Health (ASTH) stake by 12% in Q3 2026, selling an estimated $130K and leaving 23,394 shares worth $832K. The position accounts for ﹤0.01% of the portfolio, ranked #1021.

William Blair & Company first reported a position in ASTH in Q4 2025 and has held it in 4 quarters since. The position peaked at $1.24M in Q2 2026. 218 funds tracked by Wall St. Rank hold ASTH as of Q3 2026.

  • William Blair & Company held 23,394 shares of Astrana Health worth $832K as of Q3 2026.
  • William Blair & Company sold 3,292 Astrana Health shares in Q3 2026, an estimated $130K.
  • Astrana Health made up ﹤0.01% of William Blair & Company's portfolio in Q3 2026, its #1021 holding.
  • William Blair & Company first reported a position in Astrana Health in Q4 2025 and has held it in 4 quarters since.
  • William Blair & Company's Astrana Health position peaked at $1.24M in Q2 2026.
  • 218 funds tracked by Wall St. Rank held Astrana Health as of Q3 2026.

Based on William Blair & Company's 13F filing for Q3 2026, filed 10 Nov 2026.